Article
08 Aug 2025
USPTO Tightens IPR Petition Requirements
AUTHORS CONTENT
Article
11 Jun 2025
PTAB Acting Director Denies IPR Merely Because Petitioner Knew Of The Challenged Patent Over A Decade Ago
Article
26 May 2025
The En Banc Federal Circuit Clarifies What Evidence May Be Relied On For Proving Reasonable Royalty Damages
Article
22 May 2025
ITC Clarifies Scope Of The Economic Prong Of The Domestic Industry Requirement, Allowing Investments That Predate The Asserted Patent Issue Date
Article
14 May 2025
Federal Circuit Determines Meaning Of 'Ground' In IPR Estoppel Statute As Matter Of First Impression
Article
07 May 2025
The PTAB's Institution Grant Rate Has Dropped After Announcement Of The New PTAB Discretionary Denial Guidance And Briefing Procedure
Article
09 Apr 2025
USPTO Director Review Insights And PTAB Policy Shifts: Early 2025
Article
14 Mar 2025
USPTO Plunges PTAB's Fintiv Discretion Analysis Into Uncertainty
Article
20 Jan 2025
ITC Adopts First Significant Rule Changes Since 2018
Article
20 Jan 2025
Federal Circuit: Published Patent Application Filed Before Challenged Patent's Priority Date Deemed Prior Art In IPRs Under 35 U.S.C. § 102(e)
Article
21 Dec 2022
Board Denied Patent Owner's Motion To Dismiss / Terminate IPR Following Patent Owner's Withdrawal Of Appeal Of Parallel District Court Invalidity Finding
Article
26 Sep 2022
Winston Attorneys Contribute To Publication Of WG10's Commentary On Patent Litigation Best Practices: Streamlining Lower-Value Patent Cases Chapter
Article
09 Aug 2022
PTAB Grants Motion To Strike Evidence As Untimely Produced
Article
18 Jul 2022
Should Inventions Generated By AI Receive Patent Protection?
Article
23 Jun 2022
PTO Director Vidal Issues Interim Procedure Regarding Discretionary Denials Under Fintiv
Article
01 Jun 2022
Federal Circuit Holds That Delegation Of Director Review In PTAB Proceedings Does Not Violate The Constitution
Article
17 Mar 2022
Federal Circuit Limits Use Of "Admitted Prior Art" In IPR Proceedings (March 2022)
Article
11 Mar 2022
Moderna Has Standing To Appeal Because Of Risk Of Infringement Suit, But PTAB's Rejection Of Moderna's Invalidity Arguments Is Affirmed
Article
07 Mar 2022
Federal Circuit Overrules Shaw Industries And Clarifies Scope Of 35 U.S.C. § 315(E)(2) Estoppel
Article
04 Mar 2022
Federal Circuit Limits Use Of "Admitted Prior Art" In IPR Proceedings